The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
our research recent research suggests that apoe4 but not apoe3 might be able to slip slip through all of those tight junctions no not through the tight junctions the affinity of apoe4 to the lrp1 is quite higher than apoe3 and apoe2 and lrp1 is expressed at the blood-brain barrier so it could hack the system and get through endothelial lrp1 into the brain
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.